ROKU Is Setting Up for a Big Breakout

All charts in this post are powered by MarketSmith

There are currently many eyes on ROKU. Some say that too much attention is never good for a stock and it often leads to failed breakouts. I say, sometimes great setups look like great setups and there is no reason to overthink and overcomplicate things. I am long ROKU for the following reasons:

1) It crushed earnings estimates two weeks ago: analysts expected a significant loss, ROKU reported a small profit. Big earnings surprises typically lead to big moves.
2) The market reacted positively to ROKU’s earnings report: it gapped up and it closed near the highs of its earnings day’s price range. The stock has consolidated in a tight range near its all-time highs ever since.
3) There are plenty of disbelievers in the stock and the company’s product. As a result, 13% of its float is short. Short interest is often a source of future demand, especially when short sellers are forced out of their positions when a stock keeps climbing higher.
4) We are in a bull market, which means that most stocks setting up for a breakout are likely to break out and many breakouts are likely to follow through.

A break over $60 might lead to a quick move to $65-70. A close below ROKU’s 10-day EMA (currently near 55) would invalidate my thesis.

Momentum Monday – Nike and Lululemon at New All-Time Highs

All charts on Momentum Monday are powered by MarketSmith

The bull market in the U.S. is alive and well with retailers and consumer stocks leading the way. Apple keeps rising despite its enormous size. Nike and Lululemon broke to new all-time highs. Weed stocks have been on fire ever since Constellation Brands bought 40% of Canopy Growth. Dip buyers are starting to get active in Netflix, Nvidia, and Chinese stocks. Highly-shorted stocks like MTCH, DDD, and PETQ are squeezing higher. Overall, there are a lot more reasons to be bullish than bearish.

Is PetIQ Ready for a Monster Short Squeeze?

All charts in this post are powered by MarketSmith

Keep an eye on PETQ tomorrow. They make pet medications and are growing at an impressive pace: 98% quarter-over-quarter sales growth and 39% earnings per share growth. PetIQ just absolutely crushed earnings estimates, reporting $0.64 while the market expected 0.38! They also raised their full-year guidance. More importantly, the stock is up 15% after the close and it is trading at new all-time highs near $32. 37% of its tiny 14-million-shares float is short. There’s a decent potential for a short squeeze in the next few days with a target 35-40.

Here are some interesting comments on Twitter that add a fresh perspective to PetIQ’s numbers: